Free Trial

This company has been marked as potentially delisted and may not be actively trading.

ACE Convergence Acquisition (ACEVW) Competitors

ACEVW vs. LBPSW, AEHAW, ANZUW, BTMDW, CAPTW, CRGT, ELMSW, FWRLX, GMVDW, and YMAT

Should you be buying ACE Convergence Acquisition stock or one of its competitors? The main competitors of ACE Convergence Acquisition include 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Anzu Special Acquisition Corp I (ANZUW), biote (BTMDW), Captivision (CAPTW), Cortigent (CRGT), Electric Last Mile Solutions, I (ELMSW), Fidelity Select Wireless (FWRLX), G Medical Innovations (GMVDW), and J-Star (YMAT). These companies are all part of the "manufacturing" sector.

ACE Convergence Acquisition vs.

4D pharma (NASDAQ:LBPSW) and ACE Convergence Acquisition (NASDAQ:ACEVW) are both manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, community ranking, dividends and valuation.

In the previous week, 4D pharma's average media sentiment score of 0.00 equaled ACE Convergence Acquisition'saverage media sentiment score.

Company Overall Sentiment
4D pharma Neutral
ACE Convergence Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4D pharma$522KN/AN/AN/AN/A
ACE Convergence AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
4D pharmaN/A N/A N/A
ACE Convergence Acquisition N/A N/A N/A

4D pharma and ACE Convergence Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
4D pharmaN/AN/A
ACE Convergence AcquisitionN/AN/A

Summary

4D pharma beats ACE Convergence Acquisition on 1 of the 1 factors compared between the two stocks.

Remove Ads
Get ACE Convergence Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACEVW and its competitors with MarketBeat's FREE daily newsletter.

ACEVW vs. The Competition

MetricACE Convergence AcquisitionSemiconductor & Related Device Manufacturing IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$2.07B$7.84B
Dividend YieldN/AN/A2.68%4.04%
P/E RatioN/AN/A23.4018.65
Price / SalesN/AN/A71.5687.34
Price / CashN/AN/AN/A34.64
Price / BookN/AN/A1.974.11
Net IncomeN/AN/A-$389.14M$247.10M

ACE Convergence Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACEVW
ACE Convergence Acquisition
N/AN/AN/AN/A$0.00N/A0.00N/A
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
+0.5%
N/A-83.3%$0.00N/A0.002
ANZUW
Anzu Special Acquisition Corp I
N/A$0.03
+3.6%
N/A-69.0%$0.00N/A0.002
BTMDW
biote
N/A$0.07
flat
N/A-88.4%$0.00$197.19M0.00N/A
CAPTW
Captivision
N/A$0.01
-16.1%
N/A-89.1%$0.00$17.39M0.00N/AGap Up
CRGT
Cortigent
N/AN/AN/AN/A$0.00N/A0.006High Trading Volume
ELMSW
Electric Last Mile Solutions, I
N/AN/AN/AN/A$0.00N/A0.002
FWRLX
Fidelity Select Wireless
N/A$12.54
+0.3%
N/AN/A$0.00N/A0.00147,000High Trading Volume
GMVDW
G Medical Innovations
N/AN/AN/AN/A$0.00$4.42M0.0072
YMAT
J-Star
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:ACEVW) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners